Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extrapancreatic Glucagon Role in Pancreatectomised Patients
NCT02944110Unknown
- Sponsor
- Gentofte Hospital
- Start
- Apr 2016
- Primary completion
- Nov 2019
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of adomeglivant in postpancreatectomy diabetes mellitus (2 cohorts), sponsored by Gentofte Hospital. Primary endpoint: Postprandial Glucose Excursions (iAUC). Status: unknown.
02
Drugs
adomeglivant
03
Conditions
postpancreatectomy diabetes mellitus
Beyond the preview
Go deeper on NCT02944110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944110.